FDA Inspection 1296650 — Institute For Reproductive Health
The FDA completed an inspection of Institute For Reproductive Health on Dec 17, 2025 in Montgomery, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 17, 2025
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Montgomery, OH (United States)